Bianco James A.

CIK 00011985541 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001198554

Recent Transactions

50 trades

Sale
CTI BIOPHARMA CORP
Common stock
2006-01-03$2.24/sh−12,727→ 884,620 total
Sale
CTI BIOPHARMA CORP
Common stock
2006-01-03$2.25/sh−1,908→ 882,712 total
Sale
CTI BIOPHARMA CORP
Common stock
2006-01-03$2.24/sh−12,727→ 884,620 total
Sale
CTI BIOPHARMA CORP
Common stock
2006-01-03$2.25/sh−1,908→ 882,712 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-07-01$2.70/sh−9,625→ 672,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-07-01$2.70/sh−9,625→ 672,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-04-05$3.69/sh−20,000→ 709,972 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-04-05$3.68/sh−10,000→ 699,972 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-04-05$3.68/sh−10,000→ 699,972 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-04-05$3.69/sh−20,000→ 709,972 total
Award
CTI BIOPHARMA CORP
Common Stock
2005-01-10+200,000→ 729,972 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.06/sh−9,625→ 564,972 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.06/sh−9,625→ 564,972 total
Gift
CTI BIOPHARMA CORP
Common Stock
2004-12-30−35,000→ 529,972 total
Gift
CTI BIOPHARMA CORP
Common Stock
2004-12-30−35,000→ 529,972 total
Award
CTI BIOPHARMA CORP
Common Stock
2004-01-01+110,000→ 584,597 total
Award
CTI BIOPHARMA CORP
Common Stock
2004-01-01+110,000→ 584,597 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.40/sh−5,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.27/sh−4,000→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Employee stock option (right to buy)
2003-07-31−30,000→ 55,656 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.38/sh−100→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.26/sh−600→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.29/sh−4,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.33/sh−2,800→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.30/sh−5,700→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.38/sh−100→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.26/sh−600→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.29/sh−4,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.37/sh−3,400→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.40/sh−5,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.30/sh−5,700→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.25/sh−4,400→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.37/sh−3,400→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.27/sh−4,000→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Employee stock option (right to buy)
2003-07-31−30,000→ 55,656 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.25/sh−4,400→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-31$11.33/sh−2,800→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.15/sh−3,000→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.26/sh−500→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.33/sh−2,600→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.21/sh−6,228→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Common Stock
2003-07-30$2.97/sh+14,344→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Employee stock option (right to buy)
2003-07-30−23,184→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.27/sh−2,200→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.32/sh−2,400→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Common Stock
2003-07-30$2.91/sh+23,184→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Employee stock option (right to buy)
2003-07-30−23,184→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.27/sh−2,200→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.32/sh−2,400→ 0 total
Sale
CTI BIOPHARMA CORP
Common Stock
2003-07-30$11.21/sh−6,228→ 0 total

Companies

CTI BIOPHARMA CORP
Director, President & CEO

Recent Filings

Address

501 ELLIOTT AVE W SUITE 400

SEATTLE, WA, 98119

View on SEC.gov